Pharma Focus Asia
Klöckner Pentaplast - Pentapharm® alfoil® films

Techno Trends

TechnoTrends provide comprehensive coverage of the innovations and inventions in pharma products and pharma technologies across the world. The up-to-date listing of latest pharmaceutical product news and technology trends in the global pharma industry, keeps you abreast with all the latest pharmaceutical innovations happening world over.

Amgen Introduces First and Only IMDELLTRA™ T-Cell Engager Therapy for Small Cell Lung Cancer

Amgen has introduced IMDELLTRA™, the first and only T-cell engager therapy for treating extensive-stage small cell lung cancer. IMDELLTRA™ is unique as the only DLL3-targeting bispecific T-cell engager therapy...

Avidity Biosciences Discovers Novel Delpacibart Etedesiran (AOC 1001) for Myotonic Dystrophy Type 1

Avidity Biosciences has pioneered a groundbreaking treatment, del-desiran, for Myotonic Dystrophy Type 1. This investigational therapy targets the root cause...

Pfizer Launches First TIVDAK® to Treat Recurrent or Metastatic Cervical Cancer

Pfizer has introduced TIVDAK® to address the needs of patients battling recurrent or metastatic cervical cancer that has progressed despite prior chemotherapy. ...

The University of Texas MD Anderson Cancer Centre Develops Breakthrough PRAME-targeted TCR NK Cell Therapy

The University of Texas MD Anderson Cancer Centre has developed PRAME TCR/IL-15 NK, a revolutionary therapy using engineered T cell receptor natural killer cells to target relapsed/refractory myeloid malignancies....

ImmunityBio Discovered Novel Anktiva for Non-Muscle Invasive Bladder Cancer

ImmunityBio has developed a groundbreaking treatment for BCG-unresponsive non-muscle invasive bladder cancer with carcinoma in situ, called Anktiva. This innovative therapy combines Anktiva...

Kura Oncology Introduces Breakthrough Therapy for Ziftomenib in Mutant Acute Myeloid Leukaemia

Kura Oncology has introduced ziftomenib, a groundbreaking medication aimed at treating patients suffering from relapsed/refractory NPM1-mutant acute myeloid leukaemia...

Genentech Discovered First Alecensa® Treatment for Early-Stage Lung Cancer

Genentech has discovered the first-ever Alecensa® for adjuvant treatment after tumour removal in patients with anaplastic lymphoma kinase positive non-small cell lung cancer...

Johns Hopkins Medicine Developed Novel Treatment for Leukaemias and Lymphomas

Johns Hopkins Medicine has pioneered a groundbreaking treatment for T-cell leukaemias and lymphomas, addressing a critical challenge in targeting these cancers while preserving the immune system. ...

Dizal Discovered First-0f-its-kind Sunvozertinib Treatment

Dizal has discovered sunvozertinib as a groundbreaking first-line treatment for individuals with locally advanced or metastatic non-small cell lung cancer carrying epidermal growth factor receptor...

Denovo Biopharma Launches First-in-Class Liafensine for Treating Depression

Denovo Biopharma has introduced DB104, a pioneering treatment for treatment-resistant depression. Liafensine operates as a groundbreaking triple reuptake inhibitor, aiming at serotonin,...

magazine-slider-imageBIOVIA from Molecule to MedicineMFA + MMA 2024CPHI China || PMEC China 2024Asia Healthcare Week 2024Advance DoE WorkshopCPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinRehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference3rd World ADC Asia 2024LogiPharma Asia 2024